Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Ataxia, Depression, and Mental deterioration; and very common findings: Dysarthria. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 16 | Bilateral tonic-clonic seizure, Difficulty swallowing (dysphagia), Parkinsonism |
STUB1 function has not been fully characterized.
Spinocerebellar ataxia 48 is associated with mutations in the STUB1 gene on chromosome 16.
Genetic testing for STUB1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spinocerebellar ataxia 48 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 very common feature, 9 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spinocerebellar ataxia 48.
31 publications have been identified in PubMed for spinocerebellar ataxia 48. Research spans Case Report / Case Series (23%), Clinical Trial Publication (20%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 23% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:42 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
1 |
Difficulty swallowing (dysphagia) |
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Kidneys and urinary system | 1 | Urinary incontinence |
Growth and development | 1 | Cachexia |
6 |
20% |
Laboratory research | 5 | 17% |
Disease patterns and progression | 5 | 17% |
Research summaries | 4 | 13% |
Testing and diagnosis research | 3 | 10% |
Stee K (2026). [PMID: 42366163](https://pubmed.ncbi.nlm.nih.gov/42366163/). *Anim Genet*. [Case Report / Case Series]
Martakis K (2026). [PMID: 42309084](https://pubmed.ncbi.nlm.nih.gov/42309084/). *Lancet Neurol*. [Clinical Trial Publication]
Sapuppo A (2026). [PMID: 42193054](https://pubmed.ncbi.nlm.nih.gov/42193054/). *Curr Issues Mol Biol*. [Case Report / Case Series]
Rezende TJR (2026). [PMID: 41665609](https://pubmed.ncbi.nlm.nih.gov/41665609/). *Ann Clin Transl Neurol*. [Epidemiology / Natural History]
Ou L (2026). [PMID: 42374825](https://pubmed.ncbi.nlm.nih.gov/42374825/). *Mov Disord*. [Diagnostic / Biomarker]
Nakagawa Y (2026). [PMID: 42105168](https://pubmed.ncbi.nlm.nih.gov/42105168/). *Cerebellum*. [Case Report / Case Series]
Bekis Bozkurt H (2026). [PMID: 42051534](https://pubmed.ncbi.nlm.nih.gov/42051534/). *Front Immunol*. [Review / Meta-Analysis]
Bayen AB (2026). [PMID: 42274882](https://pubmed.ncbi.nlm.nih.gov/42274882/). *Cerebellum*. [Basic Science / Preclinical]
Xu M (2026). [PMID: 41421454](https://pubmed.ncbi.nlm.nih.gov/41421454/). *Neurobiol Dis*. [Basic Science / Preclinical]
Berns M (2026). [PMID: 41843312](https://pubmed.ncbi.nlm.nih.gov/41843312/). *Cerebellum*. [Case Report / Case Series]